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Nucleotide-binding domain and leucine-rich repeat (NLR) 
proteins are well-established hub proteins regulating a di-
versity of inflammatory and host defense responses in the 
immune system. Class II major histocompatibility complex 
transactivator (CII TA), nucleotide-binding oligomerization 
domain receptor 1 (NOD1), and NOD2 are founding family 
members that, respectively, control MHC-II transcription and 
peptidoglycan-induced NF-κB and MAP kinase activation, 
whereas NLRC5 regulates MHC-I gene expression (Kanne-
ganti et al., 2007; Ting et al., 2008; Geddes et al., 2009; Lup-
fer and Kanneganti, 2013). Another subset of NLRs plays 
central roles in the assembly of inflammasomes, multiprotein 
scaffolds that couple direct and indirect detection of patho-
gen- and danger-associated molecular patterns to recruit-
ment and activation of the prototype inflammatory caspase-1 
for production of bioactive IL-1β and IL-18. We distinguish 
the Nlrp1a and Nlrp1b, Nlrp3, and Nlrc4 inflammasomes, 
among several other emerging inflammasomes (Lamkanfi 
and Dixit, 2014). The NLRP1a inflammasome currently 
lacks a defined activating agent, but bacterial pathogens such 
as Salmonella enterica serovar Typhimurium, Pseudomonas 
aeruginosa, Legionella pneumophila, and Shigella flexneri 
all engage the NAIP/Nlrc4 inflammasome. The Nlrp1b 
inflammasome is triggered by anthrax lethal toxin (LeTx). 
Finally, the Nlrp3 inflammasome reacts to a broad range of 
bacterial, viral, and fungal pathogens, as well as danger-as-
sociated molecular patterns linked to autoimmune diseases 
(Lamkanfi and Dixit, 2012).
Unlike the aforementioned NLRs, the roles of NLRP2 
are ill-defined. Ectopically expressed NLRP2 was shown to 
regulate inflammasome signaling and to inhibit NF-κB ac-
tivation (Agostini et al., 2004; Bruey et al., 2004; Kinoshita 
et al., 2005; Fontalba et al., 2007). Knockdown studies have 
also suggested Nlrp2 to be essential for early mouse em-
bryogenesis (Peng et al., 2012). Despite these advances, the 
physiological roles of Nlrp2 are unknown. Here, we describe 
Nlrp2-deficient mice and report that Nlrp2 deletion al-
tered neither innate nor adaptive immune responses in ex 
vivo–stimulated leukocytes and in in vivo–challenged mice. 
However, we identified a role for oocyte-expressed Nlrp2 in 
early embryogenesis and show that Nlrp2 contributed im-
portantly to in vivo fertility with progressing maternal age. 
Thus, this work highlights Nlrp2 as a critical and selective 
regulator of oocyte quality, suggesting that NLRP2 variants 
with reduced activity may contribute to maternal age-associ-
ated fertility loss in humans.
results and dIscussIon
nlrp2 is dispensable for innate and adaptive immunity
To study the in vivo roles of Nlrp2, we generated Nlrp2-de-
ficient mice by flanking exon 5—which encodes most of 
the central NAC HT ATPase domain—with LoxP sites to 
allow Cre recombinase-assisted conditional deletion of the 
targeted exon (Fig. S1). Surprisingly, full-body Nlrp2−/− 
mice were born from heterozygous parents with expected 
Mendelian ratios, and no phenotypic abnormalities were 
noted (Table S1). To probe for putative roles of Nlrp2 in 
inflammasome regulation, we assessed IL-1β secretion from 
LPS-primed Nlrp2−/− and WT BM-derived macrophages 
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(BMDMs) after exposure to the canonical Nlrp3 inflam-
masome stimulus nigericin. The levels of IL-1β detected in 
culture supernatants of Nlrp2−/− macrophages were indis-
tinguishable from those of WT BMDMs (Fig. 1 a). In agree-
ment, pyroptosis (Fig. 1 b) and nigericin-induced caspase-1 
maturation (Fig. 1 c) were unaffected. Moreover, activation 
of neither the noncanonical Nlrp3 inflammasome (Fig. 1, 
d–f) nor that of other canonical inflammasomes was al-
tered in Nlrp2−/− macrophages in terms of IL-1β secretion, 
caspase-1 maturation, and pyroptosis induction (Fig. 1, g–o). 
Figure 1. nlrp2 deficiency alters neither inflammasome activation nor tlr-dependent cytokine production. (a–c) WT and Nlrp2−/− BMDMs 
were left untreated (ctrl) or primed with 0.5 µg ml−1 LPS for 2 h. In some setups, cells were then stimulated with 20 µM nigericin for 45 min. (d–f) WT 
and Nlrp2−/− BMDMs were left untreated or primed with the TLR2 ligand Pam3CSK4, and subsequently transfected with vehicle control or ultrapure LPS 
for 18 h. (g–i) WT and Nlrp2−/− BMDMs were left untreated or primed with 0.5 µg ml−1 LPS for 2 h. In some setups, cells were subsequently treated with 
Clostridium difficile toxin B (TcdB; 1 µg ml−1) for 5 h. (j–l) WT and Nlrp2−/− BMDMs were left untreated or primed with 0.5 µg ml−1 LPS for 2 h. Cells were 
subsequently left untreated or transfected with either vehicle control (mock) or dsDNA for 19 h. (m–o) WT and Nlrp2−/− BMDMs were left untreated or 
infected with Salmonella Typhimurium (MOI 5) for 3 h. Supernatants were analyzed for IL-1β (a, d, g, j, and m) and LDH (b, e, h, k, and n), and lysates were 
immunoblotted for caspase-1 (c, f, i, l, and o). (p) WT and Nlrp2−/− BMDMs were left untreated or infected with Salmonella Typhimurium (MOI 5) for 3 h 
before supernatants were collected and analyzed for secreted TNF. (q–t) WT and Nlrp2−/− BM-derived DCs were left untreated or stimulated with FSL-1, 
Pam3CSK4, or LPS (0.1 µg ml−1) for 6 or 24 h. Supernatants were analyzed for TNF (q and r) and IL-6 (s and t). Black arrows on Western blots denote 
procaspase-1 and the p20 subunit. Data are representative of results from three independent experiments, and cytokine and LDH data are presented as 
mean ± SD from a single representative experiment, with each condition performed in triplicate. Statistical significance was determined by Student’s t 
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Together, these results indicate that Nlrp2 is dispensable for 
known inflammasome pathways.
Although ectopically expressed Nlrp2 inhibited acti-
vation of the proinflammatory transcription factor NF-κB 
(Bruey et al., 2004; Kinoshita et al., 2005; Fontalba et al., 2007), 
we found that production levels of the NF-κB–dependent 
cytokine TNF in Salmonella Typhimurium–infected macro-
phages were not modulated by Nlrp2-deficiency (Fig. 1 p). 
Nor did we detect differential levels of TNF and IL-6 in 
Nlrp2-sufficient and -deficient DCs that have been stimulated 
for 6 or 24 h with the TLR2 ligands FSL-1 and Pam3CSK4 
or the TLR4 ligand LPS, respectively (Fig. 1, q–t).
Given that Nlrp2 appeared to be negligible for regulation 
of the examined inflammasome and TLR-induced NF-κB sig-
naling pathways, we sought to more broadly address the role 
of Nlrp2 in the immune system. To this end, we selectively 
ablated Nlrp2 expression in the hematopoietic compartment 
by breeding Nlrp2flox/flox mice to mice expressing the Cre re-
combinase under control of the mouse HS21/45-vav control 
regions. CD4+ T lymphocytes were collected and stimulated 
Figure 2. cd4+ t cell responses are not modulated by nlrp2 deficiency. (a–h) WT and Nlrp2−/− CD4+ T cells were left untreated or treated with an-
ti-CD3 (4 µg ml−1; plate-bound) and anti-CD28 (1 µg ml−1) monoclonal antibodies (a–d), or treated with phorbol 12-myristate 13-acetate (PMA; 100 ng 
ml−1) and ionomycin (1 µg ml−1) for the indicated durations (e–h). Supernatants were analyzed for secretion of IL-2 (a and e), IFN-γ (b and f), TNF (c and g), 
and IL-6 (d and h). (i) Cellularity of primary and secondary immune organs of naive WT and Nlrp2−/− mice. (j) The fraction of immune cell subsets in thymus 
of naive WT and Nlrp2−/− mice was determined. Cells were defined as CD4+CD8−, CD4+CD8+, CD4−CD8+, or CD4−CD8−. (k) The fraction of CD19−TCRβ+ 
T (right) cells and CD19+TCRβ− B cells (left) in spleen, lymph nodes, and BM of naive WT and Nlrp2−/− mice was determined. (l) Myeloid cell subsets in 
spleen of naive WT and Nlrp2−/− mice were determined. Cells were gated as CD11b+CD11c−Gr1high neutrophils and CD11b+CD11c−Gr1low/neg macrophages 
(left), or as CD11b+CD11c+ conventional DCs (right). (m) Myeloid cell subsets in BM of naive WT and Nlrp2−/− mice were determined. Cells were gated as 
CD11b+CD11c−Gr1high neutrophils and CD11b+CD11c−Gr1low/neg macrophages (left), or as CD11b+CD11c+ conventional DCs (right). Analyses were performed 
on at least three mice/genotype. Data are representative of results from at least two independent experiments, and cytokine data are presented as mean ± 
SD from a single representative experiment, with each condition performed in triplicate. Statistical significance was determined by Student’s t test; P < 0.05 
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ex vivo with anti-CD3 and anti-CD28 monoclonal antibodies 
to mimic stimulation by antigen-presenting cells. This treat-
ment regimen triggered Nlrp2−/− CD4+ T cells to produce the 
hallmark cytokines IL-2 and IFN-γ, as well as TNF and IL-6, 
with similar potency to WT CD4+ T cells (Fig. 2, a–d). Nlrp2 
deficiency also failed to modulate T cell receptor–independent 
cytokine production and lymphocyte proliferation in CD4+ T 
lymphocytes that have been treated with PMA and ionomycin 
(Fig. 2, e–h). In vivo immunophenotyping further revealed nor-
mal distribution profiles of lymphocyte and myeloid cell frac-
tions in thymus, spleen, lymph nodes, and BM of unchallenged 
full-body Nlrp2−/− mice (Fig.  2, i–m). Moreover, Nlrp2−/− 
mice had normal in vivo T cell responses in the NP-KLH in 
alum immunization model, and expected lethality rates in the 
LPS-endotoxemia model (unpublished data). Together, these 
findings suggest that unlike many other NLR family members, 
Nlrp2 is dispensable for innate and adaptive immunity.
nlrp2 is uniquely expressed in oocytes
In seeking to define the physiological role of Nlrp2, we char-
acterized its mRNA expression profile in different organs. 
In agreement with reported findings (Peng et al., 2012), a 
query of public microarray data revealed abundant expres-
sion of Nlrp2 mRNA in oocytes, whereas a variety of other 
murine tissues and cell types returned negative for Nlrp2 ex-
pression (Fig. 3 a). A similar oocyte-restricted expression pro-
file emerged from probing human expression data (Fig. 3 b). 
Quantitative RT–PCR analysis confirmed the selective ex-
pression of Nlrp2 in ovaries (containing oocytes), and its ab-
sence in the male reproductive system and somatic tissues of 
the mouse (Fig. 3, c and d). Several other NLR family mem-
bers with oocyte expression have been reported (Tong et al., 
2000; Peng et al., 2012, 2015), but unlike Nlrp2, transcripts of 
Nlrp5, Nlrp9b, and Nlrp14 were also abundantly expressed in 
the male reproductive system (testis, epididymis, and sperm; 
Figure 3. Murine nlrp2 is selectively ex-
pressed in oocytes. (a and b) Heat maps de-
picting expression levels of Nlrp2 mRNA across 
somatic (left) and reproductive (right) tissues 
and cell types in mice (a) and humans (b). 
Mouse Nlrp2 expression levels were retrieved 
from the Gene Expression Omnibus repository 
(accession code: GDS592); human data were 
obtained from Genevestigator; heat maps were 
built in Plotly software. Red indicates maximal, 
and gray minimal expression. Red indicates 
maximal, and gray minimal expression. (c and 
d) qRT-PCR analysis of Nlrp2 expression levels 
normalized to Gapdh across murine somatic 
(c) and reproductive (d) organs and tissues. 
(e) RT-PCR analysis of murine Nlrp2, Nlrp5, 
Nlrp9b, and Nlrp14 expression in male and fe-
male reproductive cells and tissues. Gapdh was 
included for normalization. Data are represen-
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Fig. 3 e). Together, these results suggest that Nlrp2 expression 
largely is confined to oocytes.
defective parthenogenetic development in nlrp2-deficient 
oocytes of mature adult mice
The observation that Nlrp2 was abundant in oocytes prompted 
us to investigate its significance for early embryogenesis. Oo-
cytes from superovulated Nlrp2−/− mice and WT controls were 
collected and analyzed for their developmental potential upon 
parthenogenetic activation with strontium chloride (Ma et 
al., 2005). Oocytes of 6–10-wk-old Nlrp2−/− mice—approx-
imating young adult age in humans—progressed through the 
two-cell, four-cell, and morula embryonic stages with normal 
efficiency (Fig. 4, a and b) and kinetics (Fig. 4 c), with ∼30% 
of both Nlrp2-sufficient and -deficient oocytes having adopted 
the morphological appearance of blastocysts 5 d after parthe-
nogenetic activation (Fig. 4, a–c). However, Nlrp2−/− oocytes 
from mice aged 22–25 wk—which approximates mature adult 
age in humans—progressed asynchronously and with signifi-
cantly reduced rates through the four-cell and morula stages 
(Fig. 5, a–c). This contrasted markedly with oocytes from sim-
ilarly aged WT mice, close to 80% of which successfully devel-
oped into blastocysts (Fig. 5 c). Instead, most Nlrp2−/− embryos 
were lost or appeared fragmented by day 5, and <10% reached 
the blastocyst stage (Fig. 5). Despite the striking age-associated 
defect in early embryogenesis, metaphase II–arrested oocytes 
collected from both 6–10- and 22–25-wk-old Nlrp2−/− mice 
had spindles of seemingly normal size and shape (Fig. S2, a–d). 
Also spindle-mediated chromosome segregation appeared to 
be grossly normal when analyzed 1  h after parthenogenetic 
Figure 4. nlrp2 is dispensable for parthenogenetic development of oocytes from young adult mice. (a) Representative bright field micrographs 
of developing embryos at days 1, 2, 3, and 5 after parthenogenetic activation of oocytes obtained from 6–10-wk-old WT and Nlrp2−/− mice. (b) Fraction of 
activated oocytes from 6–10 wk old WT and Nlrp2−/− mice that reached the indicated embryonic cleavage stages. (c) Kinetic analysis of the progression of 
activated oocytes from 6–10-wk-old WT and Nlrp2−/− mice through the indicated embryonic cleavage stages. Data represent mean ± SD of 201 oocytes 
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activation (Fig. S2, e and f). Many genes that contribute im-
portantly to early embryogenesis in mammals are subject to 
imprinting, an epigenetic process of gene silencing in repro-
ductive cells that allows selective expression of alleles in a 
parent-of-origin–dependent manner (Van Gorp et al., 2014). 
Given that the nucleotide sequences of Nlrp2 transcripts of 
C57BL/6J, BALB/c, and 129S1 mice are fully conserved in 
their open reading frames (unpublished data), naturally en-
coded Nlrp2 mRNA variants could not be exploited to dis-
tinguish maternal- and paternal-derived Nlrp2 transcripts in 
oocytes. We therefore took advantage of the differential Nlrp2 
alleles of WT and Nlrp2−/− mice to establish whether Nlrp2 
was imprinted (Fig. S3 a). After breeding Nlrp2−/− females to 
Nlrp2+/+ males, RT-PCR analysis of oocytes of the resulting 
heterozygous offspring showed the presence of transcripts cor-
responding to both the WT and knockout Nlrp2 alleles (Fig. 
S3 b), indicating that Nlrp2 is not imprinted because both the 
parental and maternal Nlrp2 alleles were actively transcribed. 
Together, these results suggest that Nlrp2 regulates early em-
bryogenesis after oocyte activation.
nlrp2 regulates maternal fertility in vivo
Although more work is needed to pinpoint the molecular 
mechanisms involved, the aforementioned findings led us to 
hypothesize that Nlrp2 may exert a role in vivo in early em-
bryogenesis that gains significance with progressing maternal 
age. To empirically address this possibility, WT and Nlrp2−/− 
females were bred to randomly selected WT and Nlrp2−/− 
males when aged 7 wk, and their reproductive performance 
was monitored over time until they became 45 wk old. No-
Figure 5. nlrp2 is required for efficient parthenogenetic development of oocytes from mature adult mice. (a) Representative bright field mi-
crographs of developing embryos at days 1, 2, 3 and 5 after parthenogenetic activation of oocytes obtained from 22–25 wk old WT and Nlrp2−/− mice. (b) 
Fraction of activated oocytes from 22–25 wk old WT and Nlrp2−/− mice that reached the indicated embryonic cleavage stages. (c) Kinetic analysis of the 
progression of activated oocytes from 22–25 wk old WT and Nlrp2−/− mice through the indicated embryonic cleavage stages. Data represent mean ± SD of 
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tably, litters were comparably sized when WT and Nlrp2−/− 
females were 9–15 wk old, but Nlrp2−/− females delivered 
significantly less pups/litter as they grew older (Fig.  6  a). 
Nlrp2 likely controls maternal fertility independently of 
inflammasomes because females lacking the central inflam-
masome proteases caspases 1 and 11 did not have reduced 
litter sizes with progressing age (Fig. 6 b). We next addressed 
whether the in vivo role of Nlrp2 in regulation of age-associ-
ated fertility extended to males. To this end, Nlrp2−/− and WT 
males that were aged >16 wk were mated with WT females 
of similar age to compare the reproductive performance of 
these breeding couples. Nlrp2−/− males had litter sizes that 
were comparable to those of WT males (Fig. 6 c), whereas a 
control group of Nlrp2−/− males that was mated to Nlrp2−/− 
females showed a significant reduction in the number of pups 
delivered per litter (Fig. 6 c). We also performed a recipro-
cal experiment in which WT males were bred to either WT 
or Nlrp2−/− females. In agreement with our other findings, 
Nlrp2−/− females had markedly less pups per litter relative 
to their WT counterparts (Fig.  6  d). These results confirm 
that Nlrp2 selectively controls maternal fertility in mature 
adult mice. To further validate and expand on these findings 
in a controlled setting, four Nlrp2−/− males of proven fertil-
ity were each co-housed with one randomly selected WT 
and one Nlrp2−/− female of >14 wk old. Litter sizes in this 
experiment were determined based on genotype of the pups 
with all heterozygous pups in the breeding cage being as-
signed to the WT female, and Nlrp2−/− pups being born from 
the knockout female. In agreement with our other observa-
tions, we found that litters of mature adult Nlrp2−/− females 
were significantly smaller than those of WT females (Fig. 6 e), 
confirming that Nlrp2 is required for optimal fertility with 
progressing maternal age.
In conclusion, we showed here that Nlrp2 selec-
tively controls maternal age-associated fertility. Together 
with the reported sterility of female mice with a hypo-
morphic Nlrp5 allele (Tong et al., 2000), our results de-
fine a growing subset of NLRs with demonstrated in vivo 
roles in maternal fertility. Defective Nlrp5 causes female 
sterility as a result of an oocyte-intrinsic inability to de-
Figure 6. nlrP2 selectively controls maternal age-associated fertility in vivo. (a) WT (n = 14) and Nlrp2−/− (n = 10) female mice were randomly 
bred to WT (n = 5) and Nlrp2−/− (n = 7) males when aged 7 wk, and size of each litter was determined until they were 45 wk of age. (b) WT (n = 8) and 
Casp1−/−Casp11−/− (C1/C11−/−; n = 8) female mice were bred when aged 7 wk to WT (n = 4) and Casp1−/−Casp11−/− (n = 5) males, respectively, and size of 
each litter was determined until they were 45 wk of age. (c) WT (n = 5) and Nlrp2−/− (n = 7) male mice aged >16 wk were bred to either WT or Nlrp2−/− fe-
males as indicated, and litter size was determined over time. (d) WT (n = 8) and Nlrp2−/− (n = 2) female mice aged >16 wk were bred to WT males, and litter 
size was determined over time. (e) Nlrp2−/− males of proven fertility (n = 4) were each placed in a separate cage and bred to one randomly selected WT and 
1 Nlrp2−/− female aged >14 wk. Litter size was determined by genotypic assignment of pups to female mice in the respective cages. Data represent mean ± 
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velop beyond the two-cell embryonic stage, whereas the 
results presented here implicate Nlrp2 in an oocyte-in-
trinsic developmental checkpoint that gains significance 
with progressing maternal age. These findings set the ex-
perimental context for future studies aimed at elucidating 
the molecular mechanisms through with NLRP2 controls 
early embryogenesis. Among other possibilities, Nlrp2 
may be a maternal effect gene that directly or indirectly 
supports proper imprinted gene expression patterns and 
pluripotency of developing zygotes under ovarian age-as-
sociated stress conditions (Barton et al., 1984; Van Gorp 
et al., 2014). Defective NLRP2 signaling may thus affect 
reproductive function in patients. Indeed, anecdotal evi-
dence links mutations in human NLRP2 with increased 
susceptibility to reproductive disorders, such as sporadic 
Beckwith-Wiedemann syndrome (Meyer et al., 2009) and 
Silver–Russell syndrome (Court et al., 2013). Moreover, 
humans encode a second (primate-specific) Nlrp2 or-
thologous gene, NLRP7, that is frequently found mutated 
in patients with familial cases of biparental molar preg-
nancies (Nguyen and Slim, 2014; Van Gorp et al., 2014). 
As increased maternal age is a prime factor driving the 
fast-growing societal demand for in vitro fertilization and 
other assisted reproductive technologies, our findings ad-
ditionally support examination of whether NLRP2 and 
NLRP7 polymorphisms impact on embryo quality and 
success rates in these patient groups. Thus, this work sheds 
light on the role of Nlrp2 as a critical checkpoint of early 
preimplantation embryogenesis, and warrants investigation 
of defective NLRP2 and NLRP7 function in women with 
early menopause manifestation and other conditions asso-
ciated with declining maternal fertility.
MaterIals and MetHods
Mice
Nlrp2floxNeo+ mice were generated at Ingenious Target-
ing Laboratory Inc. by conditional targeting of exon 5 in 
C57BL/6 embryonic stem (ES) cells. Resulting chime-
ras were bred to Flp-transgenic mice to delete the FLP 
recombinase target (FRT) sequences-flanked neomycin se-
lection cassette. Nlrp2-deficient mice were obtained after 
breeding to appropriate Cre recombinase-expressing mice. 
Casp1−/−Casp11−/− mice have been reported (Kuida et al., 
1995). All mice were housed under specific pathogen–free 
conditions, and animal studies were conducted under proto-
cols and guidelines approved by the Ghent University animal 
care and use committee (ECD14/74; ECD15/02).
Genotyping
The following primers were used for genotyping Nlrp2−/− 
mice: R1, 5′-CCT GGT GAA TCC AAT GTC TAGG-3′; F1, 
5′-GGA GCC CTG ATG ATT CTT TGG-3′; F2, 5′-CTG 
AAG TCT CTC ATT CTC TAT AGG-3′. Nlrp2+ (primers R1, 
F2), 406 bp; Nlrp2flox (primers R1, F2), 583 bp; and Nlrp2− 
(primers R1, F1), 691 bp.
oocyte collection and parthenogenetic activation
Females of the indicated age and genotypes were superovu-
lated by i.p. injection of pregnant mare serum gonadotropin 
(PMSG; 5 IU; Folligon; Intervet), 48 h later followed by i.p. 
injection of human chorionic gonadotrophin (hCG; 5 IU; 
Chorulon; Intervet). Mice were euthanized, cumulus-en-
closed oocytes were recovered and treated with hyaluronidase 
(0.3 mg/ml; H4272; Sigma-Aldrich) in M2 media (M7167-
50ML; Sigma-Aldrich) to remove cumulus cells. Oocytes 
were then washed and maintained in KSOM (MR-121-D; 
EMD Millipore) in an incubator (at 37°C and 5% CO2) for 
2 h. Subsequently, oocytes were incubated in Ca2+-free HTF 
media containing SrCl2 (10 mM) and cytochalasin D (2 µg/
ml; C8273; Sigma-Aldrich). 4 h later, embryos were washed 
and cultured further in KSOM medium in a 5% CO2 incu-
bator at 37°C. Morulas were transferred to blastocyst media 
(K-SIBM-50; Cook Medical). Developing embryos were 
analyzed under 20× objective of IX71 inverted Microscope 
by CCD Camera XM-10 (Olympus) with resolution 0.6442 
µm/pixel in Imaging software CellB (Olympus).
Immunofluorescence microscopy
Oocytes were collected from oviducts of superovulated mice, 
transferred to extraction/fixation solution (200 µl 50 mM 
Hepes, 4% paraformaldehyde, 0.2% Triton X-100, 5  mM 
MgCl2, 5 mM EGTA, pH 7.4, and 0.1 M PIP ES, pH 7.4, 
in water) in 9-well Pyrex plates (13-748B; Thermo Fisher 
Scientific) and incubated at room temperature for 1 h before 
incubation in 200 µl blocking solution (PBS; BSA [4%] and 
Tween [0.25%]) for an additional 1 h. Oocytes were stained 
with an α-tubulin antibody (1:200; T9026; Sigma-Aldrich) 
in blocking solution, washed, and incubated with a donkey 
anti–mouse IgG conjugated to Alexa Fluor 488 (A-21202; 
Thermo Fisher Scientific). Mounted samples were visualized 
under a TCS SP5 (Leica) and confocal microscopes. Spin-
dle length was measured after 3D reconstruction of 2-µm 
z-stacks using Imaris software.
rna extraction and first strand synthesis
RNA was extracted from mouse tissues using RNeasy mini 
kit (74104; QIA GEN) according to the manufacturer’s pro-
tocol. RNA concentration was measured using a NanoDrop 
ND-8000, and cDNA was synthesized using QuantiTect Re-
verse Transcription kit (205311; QIA GEN) according to the 
manufacturer’s instructions.
rt-Pcr
The following primers were used for RT-PCR analysis: 
Nlrp2F: 5′-CCC TGA AAG TAG AAA AGG CGG-3′; Nlrp2R: 
5′-CCA CTT TCT GGA GAC AAC AGG-3′; Nlrp9bF: 5′-TCA 
GAT GTA TTA TCA GTG ACT GC-3′; Nlrp9bR: 5′-GGA 
GAC ATC GAA TTA CAG AGG-3′; Nlrp5F: 5′-GCT GCT 
GAT TAA CCA GAA GAT GG-3′; Nlrp5R: 5′-GGC CCG 
TTG ACT CAG GAT GC-3′; Nlrp14F: 5′-GCT CAG CCA 
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AAG ATT GC-3′. Nlrp2 cDNAs were amplified for imprint-
ing analysis with the following primers: Nlrp2R2: 5′-AAA 
AAT GAA ATG AGG AAG AGG AGG-3′; Nlrp2F2: 5′-AGT 
GAA AGC TGG TGT GGT GG-3′. Phusion Hot Start Flex 2X 
Master Mix (M0536L; NEB) was used for PCR amplification.
qrt-Pcr
qRT-PCR was performed on a mouse normal tissue qPCR 
array (MNRT301; Origene) with the LightCycler 480 
SYBR Green I Master (4707516001; Roche) and the fol-
lowing primers: NLRP2F: 5′-CCC TGA AAG TAG AAA 
AGG CGG-3′; Nlrp2R: 5′-CCA CTT TCT GGA GAC AAC 
AGG-3′; GapdhF: 5′-GGT GAA GGT CGG TGT GAA CG-3; 
GapdhR: 5′-CTC GCT CCT GGA AGA TGG TG-3′. Nlrp2 
expression levels were normalized to Gapdh.
cell culture and reagents
BMDMs and DCs were prepared as previously described 
(Vande Walle et al., 2014). The following reagents were 
used as indicated: FSL-1 (100 ng/ml; tlrl-fsl; InvivoGen), 
Pam3CSK4 (100 ng/ml; tlrl-pms; InvivoGen), S. minnesota 
LPS (100 ng/ml or 500 ng/ml; tlrl-smlps; InvivoGen), ni-
gericin (20 µM, N7143-10MG; Sigma-Aldrich), C. difficile 
toxin B (1 µg/ml; #155L; List Biological Laboratories); Li-
pofectamine-2000 (5  µl; 11668–019; Invitrogen), Fugene 
(E2311; Promega). CD4+ T cells were purified by negative 
selection with CD4+ T cells isolation kit II (130–095-248; 
Miltenyi Biotec) according to manufacturer’s instructions. 
CD4+ T cell were activated with plate-bound anti-CD3 (4 
µg/ml; 14–0031-85; eBioscience) and anti-CD28 antibodies 
(1 µg/ml; 14–0281-82; eBioscience), or with PMA (100 ng/
ml; P1585-1MG; Sigma-Aldrich) together with ionomycin 
(1 µg/ml; I0634; Sigma-Aldrich).
cytokine and cell death assays
Cytokines were analyzed with Luminex (Bio-Rad Laborato-
ries) and ELI SA (R&D Systems) assays according to guide-
lines of the manufacturers. Cell death was determined by 
lactate dehydrogenase (LDH) assay (G1780; Promega).
Western blotting
Cell lysates and culture supernatants were incubated with 
1X Caspase Lysis Buffer (0.1% NP-40, 20 mM NaCl, 2 mM 
Tris-HCl, pH 7.4) on ice and denatured in Laemmli buffer. 
Samples were boiled and separated by SDS-PAGE. Separated 
proteins were transferred to PVDF membranes. Blocking, 
incubation with antibody, and washing of the membrane 
were done in PBS supplemented with 0.05% Tween-20 
(vol/vol) and 3% (wt/vol) nonfat dry milk. Immunoblots 
were incubated overnight with primary antibodies against 
caspase-1 (AG-20B-0042-C100; 1:1,000; Adipogen), fol-
lowed by HRP-conjugated secondary anti–mouse anti-
bodies (1:5,000; 115–035-146; Jackson ImmunoResearch 
Laboratories) to detect proteins by enhanced chemilumi-
nescence (Thermo Fisher Scientific).
Flow cytometry
Cells from primary and secondary immune organs were pre-
pared by mechanical dissociation through 70-µm cell strainers 
(08–771-2; Corning). 1–5 million cells were blocked with anti- 
mouse CD16/CD32 antibody (14–0161-85, eBioscience), 
and stained with anti-TCRβ-biotin (13–5961-81, eBiosci-
ence) followed by incubation with SA-APC (17–4317-82; 
eBioscience,) and anti-CD19-PE (12–0193-81, eBioscience) 
for spleen and LN cells; anti-B220-PE (12–0452-82; eBio-
science) for BM cells; anti-CD4-FITC (11–0041-82; eBio-
science) and anti-CD8-APC (17–0081-81; eBioscience) for 
thymocytes; and anti-CD11b-APC (17–0112-81; eBiosci-
ence), anti-GR1-FITC (11–5931-82; eBioscience) and anti- 
CD11c-PE (12–0114-81; eBioscience) for myeloid cells in 
the presence of propidium iodide for analysis of cell death. 
Cells were analyzed on a FAC SCalibur (BD) machine.
statistical analysis
Statistical analyses were performed using the Student’s t 
test in GraphPad Prism5 software. P < 0.05 was considered 
statistically significant.
online supplemental material
Fig. S1 describes production and genotyping of Nlrp2−/− 
mice. Fig. S2 shows normal spindle morphology in Nlrp2−/− 
oocytes. Fig. S3 shows that Nlrp2 is not imprinted. Table S1 
shows that Nlrp2−/− mice are born with expected Mendelian 
ratios from heterozygous parents.
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